Friday, 12 August 2011

Aromasin may prevent breast cancer, and iteration

Aromasin tablets
Photo Karl Stephan

Aromasin (exemestane) can prevent new cases of breast cancer, as well as recurrence in post menopausal women. you will also be glad to know that exemestane may soon be available in generic form, as the patent expired on April 1., which would make on a cheaper medicines, which lowers the number of newly diagnosed breast cancer cancers.

This news is the result of an investigation of NCIC clinical trials group at Queen's University in Ontario, Canada. findings were presented at this year's American Society of Clinical Oncology meeting in Chicago. New England Journal of Medicine published study, which ran for 5 years and contained more than 4,500 women living in North America, Spain, and France. women in this study were already klimakteriet, and was identified as being high risk of breast cancer.

It is not the first time that a hormonal therapy has been considered to be common for many outstanding has been prescribed chemoprevention of breast cancer-Tamoxifen. and post menopausal women after treatment for estrogen-sensitive breast cancer. it prevents return of breast cancer by blocking estrogen receptors, but it does not stop the estrogen production., and Tamoxifen on the downside for the reason that many patients do not take it for the full five yearsis the standard recipe, side effects. Tamoxifen causes menopause-related hot flashes, night sweats and raises your risk of endometrial cancers, cataracts and stroke.

Aromasin has milder side effects than Tamoxifen and works differently. blocks estrogen Tamoxifen and Aromasin prevents estrogen production. Aromasin is a flavouring aromatase inhibitor, which is often given to post menopausal breast cancer patients who have completed treatment of estrogen-sensitive breast cancer drugs will be of benefit. neither the patients, who have estrogen receptor negative breast tumours, such as Triple Negative Breast Cancer (TNBC).

Do not rush and consult your doctor to prescribe exemestane as breast cancer prevention just yet. Several studies to be carried out on the benefits and risks as well as its effectiveness to prevent the development of breast cancer tumours in high-risk women. However, if the research holds up this drug can prevent many overriding mastectomies in young and old women who have had the genetic test and found to have a strong family history, as well as a genetic predisposition to breast cancer. for those women who do not have anything against an early case of hot flashes in order to avoid a breast tumor, side effects of exemestane does not seem too bad.


View the original article here

No comments:

Post a Comment